Adrenomedullin and adrenotensin increase the transcription of regulator of G‑protein signaling 2 in vascular smooth muscle cells via the cAMP‑dependent and PKC pathways

Mao,Yuanjie; Su,Jialin; Lei,Lei; Meng,Lei; Qi,Yongfen; Huo,Yong; Tang,Chaoshu

doi:10.3892/mmr.2013.1751

Adrenomedullin and adrenotensin increase the transcription of regulator of G‑protein signaling 2 in vascular smooth muscle cells via the cAMP‑dependent and PKC pathways

Authors:
- Yuanjie Mao
- Jialin Su
- Lei Lei
- Lei Meng
- Yongfen Qi
- Yong Huo
- Chaoshu Tang
View Affiliations

Affiliations: Department of Cardiology, Peking University First Hospital, Beijing 100034, P.R. China, Department of Endocrinology, Beijing Aerospace Center Hospital, Beijing 100049, P.R. China
Published online on: October 23, 2013 https://doi.org/10.3892/mmr.2013.1751
Pages: 323-327

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The regulator of G‑protein signaling 2 (RGS2) has been shown to be crucial in the regulation of vascular tone and blood pressure. The vascular activities of adrenomedullin (ADM) and adrenotension (ADT), two natural peptides, are dependent upon the modulation of RGS2 expression. However, the effects and pathways involved in their modulation remain unknown. This study aimed to observe the changes of RGS2 expression in response to ADM and ADT in cultured vascular smooth muscle cells and to clarify the potential signaling pathways in vitro. In the present study, vascular smooth muscle cells (VSMCs) were cultured with ADM and ADT of various concentrations for different time periods, and the gene expression of RGS2 was analyzed by PCR. ADM significantly increased the gene expression at 0.5 h to ~35‑fold of that at baseline, whereas ADT marginally increased the expression after 1‑2 h. SQ22,536 and chelerythrine were used to block the protein kinase A (PKA) and PKC pathways activated by incubation with ADM. The gene expression of RGS2 was reduced by SQ22,536 only. Furthermore, when SQ22,536 and chelerythrine were added to the cells incubated with ADT, the gene expression was markedly reduced by both SQ22,536 and chelerythrine. In conclusion, ADM immediately showed a marked increase in the gene expression of RGS2 in cultured VSMCs via a cAMP‑dependent pathway and ADT gradually showed a marginal increase in the gene expression via a cAMP‑dependent pathway and a PKC pathway.

View Figures

View References

1	Münzel T, Feil R, Mülsch A, Lohmann SM, Hofmann F and Walter U: Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [Corrected]. Circulation. 108:2172–2183. 2003.
2	Ross EM and Wilkie TM: GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem. 69:795–827. 2000. View Article : Google Scholar : PubMed/NCBI
3	Hollinger S and Hepler JR: Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev. 54:527–559. 2002. View Article : Google Scholar : PubMed/NCBI
4	Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y and Mendelsohn ME: Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med. 9:1506–1512. 2003. View Article : Google Scholar : PubMed/NCBI
5	Sun X, Kaltenbronn KM, Steinberg TH and Blumer KJ: RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol. 67:631–639. 2005. View Article : Google Scholar : PubMed/NCBI
6	Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira-dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, et al: Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest. 111:12592003. View Article : Google Scholar
7	Yang J, Kamide K, Kokubo Y, Takiuchi S, Tanaka C, Banno M, Miwa Y, Yoshii M, Horio T, Okayama A, et al: Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens. 23:1497–1505. 2005. View Article : Google Scholar : PubMed/NCBI
8	Riddle EL, Rana BK, Murthy KK, Rao F, Eskin E, O’Connor DT and Insel PA: Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension. 47:415–420. 2006. View Article : Google Scholar : PubMed/NCBI
9	Kamide K, Kokubo Y, Yang J, Takiuchi S, Horio T, Matsumoto S, Banno M, Matayoshi T, Yasuda H, Miwa Y, et al: Association of intima-media thickening of carotid artery with genetic polymorphisms of the regulator of G-protein signaling 2 gene in patients with hypertension and in the general population. Hypertens Res. 34:740–746. 2011. View Article : Google Scholar : PubMed/NCBI
10	Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 192:553–560. 1993. View Article : Google Scholar : PubMed/NCBI
11	Samson WK, Resch ZT, Murphy TC, Vargas TT and Schell DA: Adrenomedullin: is there physiological relevance in the pathology and pharmacology? News Physiol Sci. 14:255–259. 1999.PubMed/NCBI
12	Ishiyama Y, Kitamura K, Ichiki Y, Sakata J, Kida O, Kangawa K and Eto T: Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 22:614–618. 1995. View Article : Google Scholar : PubMed/NCBI
13	Parkes DG and May CN: Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol. 120:1179–1185. 1997. View Article : Google Scholar : PubMed/NCBI
14	Hjelmqvist H, Keil R, Mathai M, Hübschle T and Gerstberger R: Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am J Physiol. 273:R716–R724. 1997.PubMed/NCBI
15	Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM and Nicholls MG: Adrenomedullin: a hypotensive hormone in man. Clin Sci (Lond). 92:467–472. 1997.PubMed/NCBI
16	Parkes DG: Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol. 268:H2574–H2578. 1995.PubMed/NCBI
17	Feng CJ, Kang B, Kaye AD, Kadowitz PJ and Nossaman BD: L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci. 55:PL433–PL438. 1994.PubMed/NCBI
18	Fukuhara M, Tsuchihashi T, Abe I and Fujishima M: Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol. 269:R1289–R1293. 1995.PubMed/NCBI
19	Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H and Hiramori K: Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation. 95:1214–1221. 1997. View Article : Google Scholar
20	Shirai M, Shimouchi A, Ikeda S, Ninomiya I, Sunagawa K, Kangawa K and Matsuo H: Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. Br J Pharmacol. 121:679–686. 1997. View Article : Google Scholar : PubMed/NCBI
21	Champion HC, Lambert DG, McWilliams SM, Shah MK, Murphy WA, Coy DH and Kadowitz PJ: Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat. Regul Pept. 70:161–165. 1997. View Article : Google Scholar
22	Dieplinger B, Mueller T, Kollerits B, Struck J, Ritz E, von Eckardstein A, Haltmayer M and Kronenberg F; MMKD Study Group. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int. 75:408–414. 2009. View Article : Google Scholar : PubMed/NCBI
23	Hinson JP, Kapas S and Smith DM: Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev. 21:138–167. 2000.PubMed/NCBI
24	Samson WK: Proadrenomedullin-derived peptides. Front Neuroendocrinol. 19:100–127. 1998. View Article : Google Scholar
25	Gumusel B, Chang JK, Hyman A and Lippton H: Adrenotensin: an ADM gene product with the opposite effects of ADM. Life Sci. 57:PL87–PL90. 1995. View Article : Google Scholar : PubMed/NCBI
26	Zhou L, Qiu Z, Ye C, Di L, Liu X, Tang C and Zhao Y: Vasoactive effects of adrenotensin and its interactions with adrenomedullin. Chin Med J (Engl). 113:269–271. 2000.PubMed/NCBI
27	Hitomi H, Fukui T, Moriwaki K, Matsubara K, Sun GP, Rahman M, Nishiyama A, Kiyomoto H, Kimura S, Ohmori K, Abe Y and Kohno M: Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells. J Hypertens. 24:1089–1095. 2006. View Article : Google Scholar : PubMed/NCBI
28	Muslin AJ: Tuning cardiomyocyte Gq signaling with RGS2. J Mol Cell Cardiol. 41:14–16. 2006. View Article : Google Scholar : PubMed/NCBI
29	Kehrl JH and Sinnarajah S: RGS2: a multifunctional regulator of G-protein signaling. Int J Biochem Cell Biol. 34:432–438. 2002. View Article : Google Scholar : PubMed/NCBI
30	Beltowski J and Jamroz A: Adrenomedullin - what do we know 10 years since its discovery? Pol J Pharmacol. 56:5–27. 2004.PubMed/NCBI
31	Sato A, Canny BJ and Autelitano DJ: Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun. 230:311–314. 1997. View Article : Google Scholar : PubMed/NCBI
32	Cai Y, Teng X, Pan CS, Duan XH, Tang CS and Qi YF: Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin. 31:1359–1366. 2010. View Article : Google Scholar : PubMed/NCBI
33	Takata F, Dohgu S, Nishioku T, Takahashi H, Harada E, Makino I, Nakashima M, Yamauchi A and Kataoka Y: Adrenomedullin-induced relaxation of rat brain pericytes is related to the reduced phosphorylation of myosin light chain through the cAMP/PKA signaling pathway. Neurosci Lett. 449:71–75. 2009. View Article : Google Scholar
34	Gumusel B, Chang JK, Hao Q, Hyman A and Lippton H: Adrenotensin: an adrenomedullin gene product contracts pulmonary blood vessels. Peptides. 17:461–465. 1996. View Article : Google Scholar : PubMed/NCBI
35	Qi YF, Bu DF, Niu DD, Shi YR, Wang SH, Pang YZ, Tang CS and Du JB: Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides. 23:1141–1147. 2002. View Article : Google Scholar : PubMed/NCBI
36	Cuifen Z, Lijuan W, Li G, Wei X, Zhiyu W and Fuhai L: Changes and distributions of peptides derived from proadrenomedullin in left-to-right shunt pulmonary hypertension of rats. Circ J. 72:476–481. 2008. View Article : Google Scholar : PubMed/NCBI